SARS-CoV-2 infections display tremendous interindividual variability, ranging from asymptomatic infections to life-threatening disease. Inborn errors of, and autoantibodies directed against, type I interferons (IFNs) account for about 20% of critical COVID-19 cases among SARS-CoV-2-infected individuals. By contrast, the genetic and immunological determinants of resistance to infection per se remain unknown. Following the discovery that autosomal recessive deficiency in the DARC chemokine receptor confers resistance to Plasmodium vivax, autosomal recessive deficiencies of chemokine receptor 5 (CCR5) and the enzyme FUT2 were shown to underlie resistance to HIV-1 and noroviruses, respectively. Along the same lines, we propose a strategy for identifying, recruiting, and genetically analyzing individuals who are naturally resistant to SARS-CoV-2 infection.

Andreakos, E., Abel, L., Vinh, D., Kaja, E., Drolet, B., Zhang, Q., et al. (2022). A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. NATURE IMMUNOLOGY, 23(2), 159-164 [10.1038/s41590-021-01030-z].

A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection

Novelli, G;
2022-01-01

Abstract

SARS-CoV-2 infections display tremendous interindividual variability, ranging from asymptomatic infections to life-threatening disease. Inborn errors of, and autoantibodies directed against, type I interferons (IFNs) account for about 20% of critical COVID-19 cases among SARS-CoV-2-infected individuals. By contrast, the genetic and immunological determinants of resistance to infection per se remain unknown. Following the discovery that autosomal recessive deficiency in the DARC chemokine receptor confers resistance to Plasmodium vivax, autosomal recessive deficiencies of chemokine receptor 5 (CCR5) and the enzyme FUT2 were shown to underlie resistance to HIV-1 and noroviruses, respectively. Along the same lines, we propose a strategy for identifying, recruiting, and genetically analyzing individuals who are naturally resistant to SARS-CoV-2 infection.
2022
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/03 - GENETICA MEDICA
English
Animals
COVID-19
Disease Resistance
Genetic Heterogeneity
Host-Pathogen Interactions
Humans
Phenotype
Protective Factors
Risk Assessment
Risk Factors
SARS-CoV-2
Genetic Predisposition to Disease
Andreakos, E., Abel, L., Vinh, D., Kaja, E., Drolet, B., Zhang, Q., et al. (2022). A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. NATURE IMMUNOLOGY, 23(2), 159-164 [10.1038/s41590-021-01030-z].
Andreakos, E; Abel, L; Vinh, D; Kaja, E; Drolet, B; Zhang, Q; O'Farrelly, C; Novelli, G; Rodriguez-Gallego, C; Haerynck, F; Prando, C; Pujol, A; Su, H; Casanova, J; Spaan, A; Bastard, P; Biggs, C; Bigio, B; Boisson, B; Bolze, A; Bondarenko, A; Brodin, P; Chakravorty, S; Christodoulou, J; Cobat, A; Condino-Neto, A; Constantinescu, S; Feldman, H; Fellay, J; Halwani, R; Jouanguy, E; Lau, Y; Meyts, I; Mogensen, T; Okada, S; Okamoto, K; Ozcelik, T; Pan-Hammarstrom, Q; Planas, A; Puel, A; Quintana-Murci, L; Renia, L; Resnick, I; Sediva, A; Shcherbina, A; Slaby, O; Tancevski, I; Turvey, S; Uddin, K; van de Beek, D; Zatz, M; Zawadzki, P; Zhang, S
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
41590_2021_Article_1030 (1).pdf

accesso aperto

Descrizione: A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
Tipologia: Versione Editoriale (PDF)
Licenza: Non specificato
Dimensione 1.02 MB
Formato Adobe PDF
1.02 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/288389
Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 34
social impact